A new trading day began on Friday, with Caribou Biosciences Inc (NASDAQ: CRBU) stock price down -4.42% from the previous day of trading, before settling in for the closing price of $1.81. CRBU’s price has ranged from $0.66 to $3.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -33.41%. Meanwhile, its annual earnings per share averaged 8.89%. With a float of $80.97 million, this company’s outstanding shares have now reached $93.00 million.
Let’s determine the extent of company efficiency that accounts for 147 employees. In terms of profitability, gross margin is 79.43%, operating margin of -1648.79%, and the pretax margin is -1490.94%.
Caribou Biosciences Inc (CRBU) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Caribou Biosciences Inc is 12.94%, while institutional ownership is 49.28%. The most recent insider transaction that took place on Mar 14 ’25, was worth 20,400. In this transaction President and CEO of this company bought 20,000 shares at a rate of $1.02, taking the stock ownership to the 3,369,395 shares. Before that another transaction happened on Feb 21 ’25, when Company’s Chief Legal Officer sold 3,564 for $1.35, making the entire transaction worth $4,811. This insider now owns 443,502 shares in total.
Caribou Biosciences Inc (CRBU) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.44 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.16% during the next five years compared to -33.41% drop over the previous five years of trading.
Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators
Here are Caribou Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.23 in one year’s time.
Technical Analysis of Caribou Biosciences Inc (CRBU)
Looking closely at Caribou Biosciences Inc (NASDAQ: CRBU), its last 5-days average volume was 1.08 million, which is a drop from its year-to-date volume of 1.36 million. As of the previous 9 days, the stock’s Stochastic %D was 4.22%.
During the past 100 days, Caribou Biosciences Inc’s (CRBU) raw stochastic average was set at 53.50%, which indicates a significant increase from 1.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2072 in the past 14 days, which was higher than the 0.1213 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5823, while its 200-day Moving Average is $1.4688. However, in the short run, Caribou Biosciences Inc’s stock first resistance to watch stands at $1.8283. Second resistance stands at $1.9267. The third major resistance level sits at $1.9833. If the price goes on to break the first support level at $1.6733, it is likely to go to the next support level at $1.6167. Now, if the price goes above the second support level, the third support stands at $1.5183.
Caribou Biosciences Inc (NASDAQ: CRBU) Key Stats
With a market capitalization of 160.90 million, the company has a total of 93,005K Shares Outstanding. Currently, annual sales are 9,990 K while annual income is -149,110 K. The company’s previous quarter sales were 2,350 K while its latest quarter income was -39,990 K.
